<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00554541</url>
  </required_header>
  <id_info>
    <org_study_id>07-617</org_study_id>
    <nct_id>NCT00554541</nct_id>
  </id_info>
  <brief_title>Lower Extremity Venous Hemodynamics in Obese Patients Without Clinically Significant Venous Disease</brief_title>
  <official_title>Lower Extremity Venous Hemodynamics in Obese Patients Without Clinically Significant Venous Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research project is investigating the relationship between body weight and function of&#xD;
      the leg veins using a special non-invasive technique known as venous plethysmography.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Disease of the veins include blood clots, varicose veins, leg swelling, and sores on the&#xD;
      legs. Venous disease is more common in overweight patients, but little is known as to why&#xD;
      this is the case. This research project is investigating the relationship between body weight&#xD;
      and function of the leg veins using a special non-invasive technique known as venous&#xD;
      plethysmography. We hope to investigate the reason for the relationship between body weight&#xD;
      and higher risk of vein problems.&#xD;
&#xD;
      Approximately 45 people will take part in this study. Patients will be recruited from among&#xD;
      three groups: normal weight people, overweight people, and obese people.&#xD;
&#xD;
      Resting ankle-brachial index will be measured in both lower extremities to exclude the&#xD;
      presence of peripheral arterial disease. Venous physiologic study using air plethysmography&#xD;
      with positional maneuvers will be performed. Parameters to be measured will be outflow time,&#xD;
      passive draining and refill time, and exercise venous plethysmography. All studies will be&#xD;
      performed with the Phlebotest system (Osborn Medical).&#xD;
&#xD;
      All study procedures will be done during one visit, and no further follow-up is required.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of study subjects&#xD;
  </why_stopped>
  <start_date type="Actual">November 2007</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The purpose of this study is to investigate the reason for the relationship between body weight and higher risk of venous problems.</measure>
    <time_frame>single time point</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">16</enrollment>
  <condition>Obesity</condition>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>Normal Body-Mass</arm_group_label>
    <description>BMI Index: 18.5-24.9 Ankle Brachial Index Venous physiologic study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese Body-Mass</arm_group_label>
    <description>BMI Index: 30.0-39.9 Ankle Brachial Index Venous physiologic study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morbidly Obese Body-Mass</arm_group_label>
    <description>BMI Index: ≥ 40 Ankle Brachial Index Venous physiologic study</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ankle Brachial Index Venous physiologic study</intervention_name>
    <description>Assessment of lower extremity venous disease</description>
    <arm_group_label>Morbidly Obese Body-Mass</arm_group_label>
    <arm_group_label>Normal Body-Mass</arm_group_label>
    <arm_group_label>Obese Body-Mass</arm_group_label>
    <other_name>ABI</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of the Cleveland Clinic Foundation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18-60 years old&#xD;
&#xD;
          -  BMI within one of three strata (Normal: 18.5-24.9, Obese: 30.0-39.9, Morbidly Obese: ≥&#xD;
             40)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior diagnosis of chronic venous insufficiency or venous stasis ulceration&#xD;
&#xD;
          -  Prior diagnosis of lymphedema&#xD;
&#xD;
          -  Significant lower extremity edema as determined by study investigators. Lipidemia (in&#xD;
             the absence of venous or lymphatic related edema) is acceptable.&#xD;
&#xD;
          -  Varicose veins (subcutaneous dilated vein &gt; 3 mm in diameter measured in upright&#xD;
             position). Subjects with telangiectasias and/or mild reticular veins will be eligible&#xD;
             (CEAP C1)&#xD;
&#xD;
          -  Patients who have been prescribed compression stockings by a health care provider at&#xD;
             any time in the past, aside from prophylactic use during prior hospitalization to&#xD;
             prevent VTE&#xD;
&#xD;
          -  Patients who have undergone any procedure for treatment of lower extremity varicose&#xD;
             veins, including: sclerotherapy, venous ablation, phlebectomy, or a stripping&#xD;
             procedure&#xD;
&#xD;
          -  History of DVT or SVT&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Active malignancy&#xD;
&#xD;
          -  Documented hypercoagulable state&#xD;
&#xD;
          -  Body weight exceeds weight limit of the venous air plethysmograph chair equipment&#xD;
             (approximately 375 lbs)&#xD;
&#xD;
          -  Clinical diagnosis of lower extremity peripheral arterial disease or abnormal&#xD;
             ankle-brachial index (ABI) in either lower extremity&#xD;
&#xD;
          -  History of surgical intervention involving pelvis or lower extremities&#xD;
&#xD;
          -  Pelvic or lower extremity radiation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heather Gornik, MD, RVT</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <study_first_submitted>November 5, 2007</study_first_submitted>
  <study_first_submitted_qc>November 6, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2007</study_first_posted>
  <last_update_submitted>January 29, 2017</last_update_submitted>
  <last_update_submitted_qc>January 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Heather Gornik</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

